BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11009102)

  • 1. The synthetic, oxidized C-terminal fragment of the Plasmodium berghei circumsporozoite protein elicits a high protective response.
    Roggero MA; Meraldi V; López JA; Eberl G; Romero JC; Matile H; Betschart B; Corradin G; Renggli J
    Eur J Immunol; 2000 Sep; 30(9):2679-85. PubMed ID: 11009102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A strong CD8+ T cell response is elicited using the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei together with the adjuvant QS-21: quantitative and phenotypic comparison with the vaccine model of irradiated sporozoites.
    Meraldi V; Romero JF; Kensil C; Corradin G
    Vaccine; 2005 Apr; 23(21):2801-12. PubMed ID: 15780728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-dependent elimination of infected hepatocytes.
    Wang R; Charoenvit Y; Corradin G; De La Vega P; Franke ED; Hoffman SL
    J Immunol; 1996 Nov; 157(9):4061-7. PubMed ID: 8892640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with synthetic peptides containing a defined malaria epitope induces a highly diverse cytotoxic T lymphocyte response. Evidence that two peptide residues are buried in the MHC molecule.
    Romero P; Eberl G; Casanova JL; Cordey AS; Widmann C; Luescher IF; Corradin G; Maryanski JL
    J Immunol; 1992 Mar; 148(6):1871-8. PubMed ID: 1541825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization with a circumsporozoite epitope fused to Bordetella pertussis adenylate cyclase in conjunction with cytotoxic T-lymphocyte-associated antigen 4 blockade confers protection against Plasmodium berghei liver-stage malaria.
    Tartz S; Kamanova J; Simsova M; Sebo P; Bolte S; Heussler V; Fleischer B; Jacobs T
    Infect Immun; 2006 Apr; 74(4):2277-85. PubMed ID: 16552058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OM-174, a new adjuvant with a potential for human use, induces a protective response when administered with the synthetic C-terminal fragment 242-310 from the circumsporozoite protein of Plasmodium berghei.
    Meraldi V; Audran R; Romero JF; Brossard V; Bauer J; López JA; Corradin G
    Vaccine; 2003 Jun; 21(19-20):2485-91. PubMed ID: 12744882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elicitation of specific cytotoxic T cells by immunization with malaria soluble synthetic polypeptides.
    Blum-Tirouvanziam U; Beghdadi-Rais C; Roggero MA; Valmori D; Bertholet S; Bron C; Fasel N; Corradin G
    J Immunol; 1994 Nov; 153(9):4134-41. PubMed ID: 7930617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of protective CTL responses against the Plasmodium yoelii circumsporozoite protein by immunization with peptides.
    Franke ED; Corradin G; Hoffman SL
    J Immunol; 1997 Oct; 159(7):3424-33. PubMed ID: 9317141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A T cell clone directed at the circumsporozoite protein which protects mice against both Plasmodium yoelii and Plasmodium berghei.
    Weiss WR; Berzofsky JA; Houghten RA; Sedegah M; Hollindale M; Hoffman SL
    J Immunol; 1992 Sep; 149(6):2103-9. PubMed ID: 1517574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete protection against P. berghei malaria upon heterologous prime/boost immunization against circumsporozoite protein employing Salmonella type III secretion system and Bordetella adenylate cyclase toxoid.
    Tartz S; Rüssmann H; Kamanova J; Sebo P; Sturm A; Heussler V; Fleischer B; Jacobs T
    Vaccine; 2008 Nov; 26(47):5935-43. PubMed ID: 18804138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MHC class I-dependent presentation of exoerythrocytic antigens to CD8+ T lymphocytes is required for protective immunity against Plasmodium berghei.
    White KL; Snyder HL; Krzych U
    J Immunol; 1996 May; 156(9):3374-81. PubMed ID: 8617963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C3d-defined complement receptor-binding peptide p28 conjugated to circumsporozoite protein provides protection against Plasmodium berghei.
    Bergmann-Leitner ES; Duncan EH; Leitner WW; Neutzner A; Savranskaya T; Angov E; Tsokos GC
    Vaccine; 2007 Nov; 25(45):7732-6. PubMed ID: 17931754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa.
    Dobaño C; Doolan DL
    Mol Immunol; 2007 Apr; 44(11):3037-48. PubMed ID: 17303242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-12p40-independent induction of protective immunity upon multiple Plasmodium berghei irradiated sporozoite immunizations.
    Romero JF; Ibrahim GH; Renggli J; Himmelrich H; Graber P; Corradin G
    Parasite Immunol; 2007 Nov; 29(11):541-8. PubMed ID: 17944743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization of retrovirus-transfected dendritic cells induces specific cytotoxic T lymphocytes for two distinct malarial peptides presented by Kd molecule.
    Hetttihewa LM
    Int Immunopharmacol; 2003 Oct; 3(10-11):1401-11. PubMed ID: 12946436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct T cell specificities are induced with the authentic versus recombinant Plasmodium berghei circumsporozoite protein.
    Krzych U; Jareed T; Link HT; Loomis LD; Ballou WR
    J Immunol; 1992 Apr; 148(8):2530-8. PubMed ID: 1348519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmodium falciparum CS C-terminal fragment: preclinical evaluation and phase I clinical studies.
    Roggero MA; Weilenmann C; Bonelo A; Audran R; Renggli J; Spertini F; Corradin G; López JA
    Parassitologia; 1999 Sep; 41(1-3):421-4. PubMed ID: 10697896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of circumsporozoite protein-specific T-cells in protective immunity against Plasmodium berghei.
    Krzych U; White K; Link HT; Sadoff J; Lanar D; Ballou WR; Jareed T; Agarwal A
    Bull World Health Organ; 1990; 68 Suppl(Suppl):88-93. PubMed ID: 2094596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The N-terminal domain of Plasmodium falciparum circumsporozoite protein represents a target of protective immunity.
    Bongfen SE; Ntsama PM; Offner S; Smith T; Felger I; Tanner M; Alonso P; Nebie I; Romero JF; Silvie O; Torgler R; Corradin G
    Vaccine; 2009 Jan; 27(2):328-35. PubMed ID: 18984024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune response gene regulation of immunity to Plasmodium berghei sporozoites and circumsporozoite protein vaccines. Overcoming genetic restriction with whole organism and subunit vaccines.
    Hoffman SL; Berzofsky JA; Isenbarger D; Zeltser E; Majarian WR; Gross M; Ballou WR
    J Immunol; 1989 May; 142(10):3581-4. PubMed ID: 2497175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.